Cebranopadol not checked
Adneuris Therapeutics, Inc. · Tris Pharma, Inc. · GRT6005 · TRN-228
FollowEvery change as it happens, and a Monday email
Trials
13 active
35 in total · 17 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Participants receive Cebranopadol 400 mcg once per day for 14 days or until pain resolves, whichever occurs first.”In the company’s words, NCT07845071 on ClinicalTrials.gov
- Tested for
- Pain (2 trials), Chronic Pain, Opioid Withdrawal (Disorder), Opioid Use Disorder
- Main trialPhase 3
- “The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.”In the company’s words, NCT07845071 on ClinicalTrials.gov
- Other names
- GRT6005 · TRN-228 · Experimental · Treatment Phase · Morphine
Other drugs for Pain
- DapansutrileOlatec Therapeutics, Inc. · Phase 2/3
- DLBS1442Dexa Medica Group · Phase 2/3
- CombogesicAFT Pharmaceuticals, Ltd. · Phase 3
- Product DNN.63.18.040Ache Laboratorios Farmaceuticos S.A. · Phase 3
- Urcosimod ophthalmicOkyo Pharma Ltd · Phase 3
- Pregabalin XRBrainfarma Industria Química e Farmacêutica S/A · Phase 3
Coming up2
- Jan 2027Phase 3 trial completes · ClinicalTrials.gov
- Mar 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials35
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Jan 2027 | An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin | |
| Phase 2Recruiting | Mar 2027 | A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain | |
| Phase 3Terminated | 16 Oct 2015 | CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer | |
| Phase 3Completed | Apr 2016 | CORAL XT - Open-label Extension Trial of the CORAL Trial | |
| Phase 3Completed | 30 Dec 2024 | A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty | |
| Phase 3Completed | 31 Jan 2025 | A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy | |
| Phase 2Completed | Aug 2009 | Bunionectomy Trial With GRT6005 | |
| Phase 2Completed | May 2010 | Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic | |
| Phase 2Completed | Dec 2011 | Assessment of GRT6005 in Painful Osteoarthritis of the Knee | |
| Phase 2Completed | Jan 2012 | Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy | |
| Phase 2Completed | Apr 2014 | Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain | |
| Phase 2Completed | Jul 2014 | Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain. | |
| Phase 2Completed | Jan 2015 | Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves | |
| Phase 1Completed | 27 Nov 2013 | Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects | |
| Phase 1Completed | 17 Sep 2014 | A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol | |
| Phase 1Completed | 12 Jul 2022 | Assessment of Abuse Potential of Cebranopadol in Humans | |
| Phase 1Completed | 30 Mar 2023 | Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain. | |
| Phase 1Completed | 6 Nov 2024 | A Study to Assess the Abuse Potential of Intranasal Cebranopadol | |
| Phase 2Ended | not given | MORPHINE PHARMACOKINETICS AND –DYNAMICS IN HEALTHY VOLUNTEERS AND PATIENTS WITH OBESITY AND OBSTRUCTIVE SLEEP APNOEA. -AN INVESTIGATOR INITIATED, CLINICAL STUDY OF THE IMPACT OF OBESITY AND SLEEP APNOEA ON THE PHARMACOLOGY OF MORPHINE | |
| Phase 4Authorised | not given | Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung Disease | |
| Phase 3Authorised | not given | Effekten av intrathekalt morfin eller intravenöst lidokain på postoperativ återhämtning efter robotassisterad övre urologisk kirurgi. Randomiserad assessor-blindad multicenterstudie. | |
| Phase 2/3Authorised | not given | AntaMIn - Pain reduction for limb injuries in pediatric emergency departments: A Randomised Clinical Trial comparing intranasal Fentanyl or intranasal Ketamine to oral morphine | |
| Phase 4Ended | not given | Efficacy of Intrathecal Morphine for Postoperative Analgesia with or without Suprainguinal Fascia Iliaca Block After Total Hip Arthroplasty: A Double-Blind Randomized Clinical Trial | |
| Phase 4Authorised | not given | Clairance de la morPHinE et filtration glomérulaire chez le Drepanocytaire en crise en REAnimation_PHEDREA | |
| Phase 3Ended | not given | Risk-benefit analysis of intrathecal morphine administration to patients undergoing surgical treatment of proximal femoral fracture (monocentric, single-blinded, randomized clinical study compared to standard treatment) | |
| Phase 4Ended | not given | Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer | |
| Phase 4Ended | not given | Midazolam and mORPHine to alleviate symptoms at the End of life in patients on acUte geriatric wardS (MORPHEUS study) | |
| Phase 2Ended | not given | Morphine effects on stress response and social interaction – an exploratory randomized controlled experimental medicine study | |
| Phase 4Authorised | not given | Affective effects of pre-surgery opioids (AFFECT2): a randomized, doubleblind placebo-controlled trial | |
| Phase 4Authorised | not given | MOTHER trial: Efficacy and safety of low-dose intrathecal morphine following planned caesarean section - a randomised, blinded, clinical, controlled, multicentre trial. | |
| Phase 4Authorised | not given | Intrathecal drug delivery systems versus comprehensive medical management for severe cancer pain: a randomized controlled trial | |
| Phase 3Authorised | not given | Sustained-release oral morphine to alleviate persistent dyspnea in patients with chronic respiratory insufficiency due to amyotrophic lateral sclerosis outside the administration of ventilatory assistance: prospective multicenter randomized, placebo-controlled study, parallel arms. (OPIDYS-ALS). | |
| Phase 4Authorised | not given | TRAMORNOT: Tramadol versus morphine in postoperative analgesia after laparoscopic abdominal surgery: a randomized controlled trial | |
| Phase 4Authorised | not given | Morphine for resting breathlessness in severe illness and palliative care (MORE-B): a randomized clinical trial | |
| Phase 4Authorised | not given | POISON – Perioperative Safety and Effective Opioid Dosing in Chronic Opioid Use – a Randomized Clinical Study |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026